Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy.
| Autor: | Al'Aref, Subhi J, Altibi, Ahmed M, Malkawi, Abdallah, Mansour, Munthir, Baskaran, Lohendran, Masri, Ahmad, Rahmouni, Hind, Abete, Raffaele, Andreini, Daniele, Aquaro, Giovanni, Barison, Andrea, Bogaert, Jan, Camastra, Giovanni, Carigi, Samuela, Carrabba, Nazario, Casavecchia, Grazia, Censi, Stefano, Cicala, Gloria, Conte, Edoardo, Cecco, Carlo N De |
|---|---|
| Předmět: |
ECHOCARDIOGRAPHY
CAUSES of death VENTRICULAR ejection fraction CONFIDENCE intervals MAGNETIC resonance imaging IMPLANTABLE cardioverter-defibrillators RIGHT ventricular dysfunction KAPLAN-Meier estimator DESCRIPTIVE statistics RESEARCH funding HEART failure LONGITUDINAL method PROPORTIONAL hazards models |
| Zdroj: | European Heart Journal - Cardiovascular Imaging; Apr2023, Vol. 24 Issue 4, p472-482, 11p |
| Abstrakt: | Aims Right ventricular systolic dysfunction (RVSD) is an important determinant of outcomes in heart failure (HF) cohorts. While the quantitative assessment of RV function is challenging using 2D-echocardiography, cardiac magnetic resonance (CMR) is the gold standard with its high spatial resolution and precise anatomical definition. We sought to investigate the prognostic value of CMR-derived RV systolic function in a large cohort of HF with reduced ejection fraction (HFrEF). Methods and results Study cohort comprised of patients enrolled in the CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DefibrillAtor ThErapy registry who had HFrEF and had simultaneous baseline CMR and echocardiography (n = 2449). RVSD was defined as RV ejection fraction (RVEF) <45%. Kaplan–Meier curves and cox regression were used to investigate the association between RVSD and all-cause mortality (ACM). Mean age was 59.8 ± 14.0 years, 42.0% were female, and mean left ventricular ejection fraction (LVEF) was 34.0 ± 10.8. Median follow-up was 959 days (interquartile range: 560–1590). RVSD was present in 936 (38.2%) and was an independent predictor of ACM (adjusted hazard ratio = 1.44; 95% CI [1.09–1.91]; P = 0.01). On subgroup analyses, the prognostic value of RVSD was more pronounced in NYHA I/II than in NYHA III/IV, in LVEF <35% than in LVEF ≥35%, and in patients with renal dysfunction when compared to those with normal renal function. Conclusion RV systolic dysfunction is an independent predictor of ACM in HFrEF, with a more pronounced prognostic value in select subgroups, likely reflecting the importance of RVSD in the early stages of HF progression. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|